An investigation into the structural determinants of cannabinoid receptor ligand efficacy
- PMID: 10323589
- PMCID: PMC1565939
- DOI: 10.1038/sj.bjp.0702469
An investigation into the structural determinants of cannabinoid receptor ligand efficacy
Abstract
1. A number of side-chain analogues of delta8-THC were tested in GTPgammaS binding assay in rat cerebellar membranes. O-1125, a saturated side-chain compound stimulated GTPgammaS binding with an Emax of 165.0%, and an EC50 of 17.4 nM. 2. O-1236, O-1237 and O-1238, three-enyl derivatives containing a cis carbon-carbon double bond in the side-chain, stimulated GTPgammaS binding, acting as partial agonists with Emax values ranging from 51.3-87.5% and EC50 values between 4.4 and 29.7 nM. 3. The stimulatory effects of O-1125, O-1236, O-1237 and O-1238 on GTPgammaS binding were antagonized by the CB1 receptor antagonist SR 141716A. The K(B) values obtained ranged from 0.11-0.21 mM, suggesting an action at CB1 receptors. 4. Five-ynyl derivatives (O-584, O-806, O-823, O-1176 and O-1184), each containing a carbon-carbon triple bond in the side-chain, did not stimulate GTPgammaS binding and were tested as potential cannabinoid receptor antagonists. 5. Each -ynyl compound antagonized the stimulatory effects of four cannabinoid receptor agonists on GTPgammaS binding. The K(B) values obtained, all found to be in the nanomolar range, did not differ between agonists or from cerebellar binding affinity. 6. In conclusion, alterations of the side-chain of the classical cannabinoid structure may exert a large influence on affinity and efficacy at the CB1 receptor. 7. Furthermore, this study confirms the ability of the GTPgammaS binding assay to assess discrete differences in ligand efficacies which potentially may not be observed using alternative functional assays, thus providing a unique tool for the assessment of the molecular mechanisms underlying ligand efficacies.
Figures






Similar articles
-
Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.Br J Pharmacol. 2001 Jan;132(2):525-35. doi: 10.1038/sj.bjp.0703827. Br J Pharmacol. 2001. PMID: 11159703 Free PMC article.
-
Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.J Pharmacol Exp Ther. 1998 May;285(2):553-60. J Pharmacol Exp Ther. 1998. PMID: 9580597
-
Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.J Neurosci Res. 2001 May 15;64(4):429-36. doi: 10.1002/jnr.1094. J Neurosci Res. 2001. PMID: 11340650
-
Ligand based structural studies of the CB1 cannabinoid receptor.J Pept Res. 2002 Dec;60(6):348-56. doi: 10.1034/j.1399-3011.2002.21069.x. J Pept Res. 2002. PMID: 12464113 Review.
-
Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex models.Trends Pharmacol Sci. 1990 Jan;11(1):17-22. doi: 10.1016/0165-6147(90)90036-8. Trends Pharmacol Sci. 1990. PMID: 2408209 Review.
Cited by
-
Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.Eur J Pharmacol. 2011 Jan 25;651(1-3):96-105. doi: 10.1016/j.ejphar.2010.10.085. Epub 2010 Nov 27. Eur J Pharmacol. 2011. PMID: 21114999 Free PMC article.
-
Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.Br J Pharmacol. 2001 Jan;132(2):525-35. doi: 10.1038/sj.bjp.0703827. Br J Pharmacol. 2001. PMID: 11159703 Free PMC article.
-
Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine.Br J Pharmacol. 2000 Feb;129(4):645-52. doi: 10.1038/sj.bjp.0703094. Br J Pharmacol. 2000. PMID: 10683188 Free PMC article.
-
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.Pharmacol Biochem Behav. 2010 Jun;95(4):434-42. doi: 10.1016/j.pbb.2010.03.004. Epub 2010 Mar 21. Pharmacol Biochem Behav. 2010. PMID: 20332000 Free PMC article.
-
Ligand Binding Sensitivity of the Extracellular Loop Two of the Cannabinoid Receptor 1.Drug Dev Res. 2010 Nov 1;71(7):404-411. doi: 10.1002/ddr.20388. Drug Dev Res. 2010. PMID: 21170298 Free PMC article.
References
-
- BRADFORD M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254. - PubMed
-
- BURKEY T.H., QUOCK R.M., CONSROE P., ROESKE W.R., YAMAMURA H.I. Δ9-tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. Eur. J. Pharmacol. 1997;323:R3–R4. - PubMed
-
- CHENG Y.C., PRUSOFF W.H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) on an enzymatic reaction. Biochem. Pharmacol. 1973;22:3099–3108. - PubMed
-
- CHILDERS S.R., SNYDER S.H. Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J. Neurochem. 1980;34:583–593. - PubMed
-
- COMPTON D.R., RICE K.C., DE COSTA B.R., RAZDAN R.K., MELVIN L.S., JOHNSON M.R., MARTIN B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 1993;265:218–226. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials